"We are experiencing high demand for our expertise in pharmacokinetics and overall clinical pharmacology drug development services,” said Chief Scientific Officer M. Alexander Shaw, Ph.D., adding, "Our complete knowledge of clinical pharmacology and high-quality scientific writing is paying dividends for our clients and their drug pipelines.”
According to Dr. Shaw, small biopharmaceutical companies with minimal R&D infrastructure as well as mid-sized and large pharmaceutical companies are seeking access to the firm’s expertise with both traditional and population PK capabilities at an affordable cost.
In response to its increase in clientele, ClinPharm Consulting has secured a larger office space that will allow for further expansion and additional staff. The company is actively refining its internal processes and structure to accommodate new employees, while ensuring continued focus on quality, customer service, and value.
